What topics does this cannabis study cover?

This study covers research on: Neuroprotection, Mental Health.

Where was this research published?

Published in The Journal of biological chemistry on May 27, 2026.

How prenatal cannabis exposure damages developing brains

Q: What did this research study find?

Prenatal exposure to *THC*, the primary psychoactive compound in cannabis, may cause lasting damage to brain development and memory function, according to new research in adolescent animal models. Scientists found that offspring exposed to *THC* during pregnancy showed **significant memory impairmen

Prenatal cannabinoid exposure alters excitation-inhibition balance through glutamate and GABA receptor-mediated signaling.

The Journal of biological chemistry • May 27, 2026 • Moderately Relevant

🤖

AI Summary

Prenatal exposure to THC, the primary psychoactive compound in cannabis, may cause lasting damage to brain development and memory function, according to new research in adolescent animal models. Scientists found that offspring exposed to THC during pregnancy showed significant memory impairments and disrupted synaptic plasticity—the brain's ability to form and strengthen connections. The study revealed that prenatal THC altered the delicate balance between excitatory and inhibitory signaling in the hippocampus, the brain region critical for learning and memory, by reducing glutamate-receiving proteins while boosting inhibitory signaling pathways.

These findings demonstrate that the brain doesn't simply bounce back after prenatal cannabis exposure. The researchers identified specific molecular changes in hippocampal circuits, including reduced AMPAR-mediated transmission and reorganized inhibitory networks involving GABA signaling and CB1 receptors. The disrupted balance between excitation and inhibition (E/I imbalance) persisted into adolescence, suggesting the effects may be long-lasting and potentially extend into adulthood.

The research highlights an important public health concern as cannabis use during pregnancy continues to rise, often based on misconceptions about its safety. The study suggests that therapeutic interventions targeting GABA signaling could potentially help reverse cognitive deficits caused by prenatal THC exposure. These findings underscore the critical importance of avoiding cannabis during pregnancy, particularly given mounting evidence that the developing brain may be uniquely vulnerable to THC's effects during this sensitive developmental window.

📄 Original Abstract

The growing perception that marijuana is safe during pregnancy has led to a marked increase in prenatal cannabis use, raising concerns about its long-term effects on brain development and cognition. This study investigated the consequences of prenatal delta-9-tetrahydrocannabinol (THC) exposure on hippocampal circuit function, synaptic plasticity, and memory in adolescent offspring using a rodent model. We found that prenatal THC exposure resulted in persistent deficits in hippocampal-dependent memory and significant disruptions in synaptic plasticity, including impaired long-term potentiation (LTP) and increased long-term depression (LTD). Electrophysiological analyses revealed reduced AMPAR-mediated synaptic transmission and a shift toward increased inhibitory signaling, suggesting an excitation/inhibition (E/I) imbalance in the hippocampus. These functional changes were accompanied by selective downregulation of postsynaptic glutamatergic proteins (GluA1, GluN2A, GluN2B, and PSD95), while presynaptic glutamate markers remained unchanged. Notably, immunohistochemical and anatomical analyses demonstrated region-specific reorganization of inhibitory networks, including altered distribution and co-localization of cannabinoid 1 receptor (CB1R) and vesicular GABA transporter (VGAT) across hippocampal subregions. Together, our results reveal that prenatal THC exposure leads to coordinated functional and structural remodeling of hippocampal circuits, producing a lasting E/I imbalance and memory impairments during adolescence. These findings highlight disrupted GABAergic signaling as a potential therapeutic target for mitigating cognitive deficits resulting from prenatal cannabis exposure.

Paper Type

📄 Research

Publication

Journal: The Journal of biological chemistry
Published: May 27, 2026
PMID: 42208900
DOI: 10.1016/j.jbc.2026.113196

Authors (15)

Priyanka D Pinky Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849; Center for Neuroscience Initiative, Auburn University, Auburn, AL 36849.
Warren D Smith Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849; Center for Neuroscience Initiative, Auburn University, Auburn, AL 36849.
Miles T Wiley Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849; Center for Neuroscience Initiative, Auburn University, Auburn, AL 36849.
Jenna Bloemer Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849; Center for Neuroscience Initiative, Auburn University, Auburn, AL 36849; Department of Pharmaceutical Sciences, Mercer University College of Pharmacy, Atlanta, GA 30341.
Vasiliki Syropoulou Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849; Center for Neuroscience Initiative, Auburn University, Auburn, AL 36849.
+10 more authors